Headquarters : Orexo AB, P.O. Box 303, 751 05 Uppsala, Sweden
Visiting Address : Rapsgatan 7E, Uppsala, Sweden
E-mail: info@orexo.com
Phone: +46 (0)18 780 88 00
VAT NO. : SE556500-060001
Website : www.orexo.com
Subsidiary
The United States of America
Orexo US Inc., 150 Headquarters Plaza, East Tower, Morristown, New Jersey 07960, United States
E-mail: info-us@orexo.com
Phone: +1 (0)855 982 7658
Medical Inquiries/ Adverse Events/ Product Complaints : 1-888-982-7658 (8:00am to 5:30pm ET) or 1-913-339-8424 after-hours
Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap. Orexo develops improved pharmaceuticals and digital therapies addressing unmet needs within the growing space of mental illness and addiction disorders. The products are commercialized by Orexo in the US or via partners worldwide.
Comments
Post a Comment